AGENUS INC

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $114.2M $103.5M $156.3M $98.0M $295.7M $88.2M $150.0M $36.8M
Cost of Revenue $1.0M $486.0K $3.1M $10.6M $3.5M $2.3M
Gross Profit $113.2M $103.0M $153.2M $87.5M $292.2M $85.8M
Gross Margin 99.1% 99.5% 98.0% 89.2% 98.8% 97.3%
Operating Expenses
Research & Development $79.3M $155.5M $234.6M $186.7M $178.6M $142.6M $168.3M $124.6M
SG&A Expense $54.4M $71.9M $78.7M $81.0M $76.4M $59.2M $46.0M $37.3M
Operating Income $-20.2M $-120.5M $-159.5M $-179.4M $25.7M $-117.2M $-70.1M $-123.8M
Operating Margin -17.7% -116.4% -102.1% -183.0% 8.7% -133.0% -46.7% -336.6%
Interest Expense
Pretax Income $-3.1M $-232.3M $-257.4M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-3.1M $-232.3M $-257.4M $-230.7M $-28.7M $-182.9M $-111.6M $-162.0M
Net Margin -2.7% -224.5% -164.7% -235.3% -9.7% -207.4% -74.3% -440.5%
EPS (Basic) $0.00 $-10.59 $-13.75 $-15.64 $0.00 $-0.02 $-0.01 $-0.02
EPS (Diluted) $0.00 $-10.59 $-13.75 $-15.64 $0.00 $-0.02 $-0.01 $-0.02
Shares Outstanding (Basic) 29.7M 21.5M 17.9M 14.1M 14.2M 10.7M 8.32B 6.36B
Shares Outstanding (Diluted) 29.7M 21.5M 17.9M 14.1M 14.2M 10.7M 8.32B 6.36B
Dividends Per Share
← Newer Page 1 of 3 Older →